12 results on '"Sá MB"'
Search Results
2. Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis
- Author
-
Dimopoulos, G, Paiva, Ja, Meersseman, W, Pachl, J, Grigoras, I, Sganga, Gabriele, Montravers, P, Auzinger, G, Sá, Mb, Miller, Pj, Marček, T, Kantecki, M, Ruhnke, M., Sganga, Gabriele (ORCID:0000-0001-5079-0395), Dimopoulos, G, Paiva, Ja, Meersseman, W, Pachl, J, Grigoras, I, Sganga, Gabriele, Montravers, P, Auzinger, G, Sá, Mb, Miller, Pj, Marček, T, Kantecki, M, Ruhnke, M., and Sganga, Gabriele (ORCID:0000-0001-5079-0395)
- Abstract
Post hoc analysis of a non-comparative, prospective, multicentre, phase IIIb study was performed to compare efficacy and safety of anidulafungin in elderly (≥65 years) versus non-elderly (<65 years) Intensive Care Unit (ICU) patients with candidaemia/invasive candidiasis (C/IC). Adult ICU patients with confirmed C/IC meeting ≥1 of the following criteria were enrolled: post-abdominal surgery; solid tumour; renal/hepatic insufficiency; solid organ transplantation; neutropenia; age ≥65 years. Patients received anidulafungin (200mg on Day 1, 100mg/day thereafter) for ≥10 days followed by optional azole step-down therapy for a total treatment duration of 14-56 days. The primary efficacy endpoint was global (clinical and microbiological) response at the end of all therapy (EOT). Primary efficacy analysis was performed in the modified intent-to-treat (mITT) population (n=170), excluding unknown and missing responses. In total, 80 patients (47.1%) were aged ≥65 years and 90 (52.9%) were aged <65 years; the mean age difference between the two groups was 21.9 years. Global success at EOT in mITT patients was similar in elderly (68.1%) and non-elderly (70.7%) patients (P=0.719). However, global success rates were significantly lower in elderly versus non-elderly patients at 2 and 6 weeks after EOT (P=0.045 and P=0.016, respectively). Ninety-day survival was significantly lower (P=0.006) for elderly (42.8%) versus non-elderly patients (63.3%). The incidence and profile of adverse events were similar in elderly and non-elderly patients. Anidulafungin was effective and safe for treatment of C/IC in elderly ICU patients, despite higher baseline severity of illness scores
- Published
- 2012
3. Colaboradores
- Author
-
Adappa, Nithin D., Adelson, Robert T., Antunes, Marcelo B., Becker, Daniel G., Becker, Samuel S., Bleier, Benjamin S., Blount, Angela, Chandra, Rakesh K., Chiu, Alexander G., Citardi, Martin, Cohen, Noam, Conley, David B., Fakhri, Samer, Fernandez, Francisca I., Filho, Leonardo Lopes Balsalobre, Govindaraj, Satish, Harvey, Richard J., Hwang, Peter H., Iloreta, Alfred Marc C., Jaber, James J., Joe, Stephanie A., Kingdom, Todd T., Lee, Jivianne T., Lee, John M., Leung, Randy, Luong, Amber, Man, Li-Xing, Mantravadi, Avinash V., Naidoo, Yuresh, Nayak, Jayakar V., O’Malley, Bert W., Jr., Orlandi, Richard R., Palmer, James N., Pearlman, Aaron N., Phillips, P. Seamus, Pignatari, Shirley Shizue Nagata, Pittman, Amy L., Ramakrishnan, Vijay R., Reed, Jeremy, Sacks, Raymond, Schlosser, Rodney J., Simonsen, Andrew R., Sindwani, Raj, Son, Hwa J., Stamm, Aldo Cassol, Suh, Jeffrey D., Tsao, Gabriel J., Turner, Justin H., Vandergrift, William Alexander, III, Wang, Eric W., Waters, Heather H., Welch, Kevin C., Woodworth, Bradford A., and Wormald, P.J.
- Published
- 2014
- Full Text
- View/download PDF
4. Contributors
- Author
-
Adappa, Nithin D., Adelson, Robert T., Antunes, Marcelo B., Becker, Daniel G., Becker, Samuel S., Bleier, Benjamin S., Blount, Angela, Chandra, Rakesh K., Chiu, Alexander G., Citardi, Martin, Cohen, Noam, Conley, David B., Fakhri, Samer, Fernandez, Francisca I., Balsalobre Filho, Leonardo Lopes, Govindaraj, Satish, Harvey, Richard J., Hwang, Peter H., Iloreta, Alfred Marc C., Jaber, James J., Joe, Stephanie A., Kingdom, Todd T., Lee, Jivianne T., Lee, John M., Leung, Randy, Luong, Amber, Man, Li-Xing, Mantravadi, Avinash V., Naidoo, Yuresh, Nayak, Jayakar V., O’Malley, Bert W., Orlandi, Richard R., Palmer, James N., Pearlman, Aaron N., Seamus Phillips, P., Nagata Pignatari, Shirley Shizue, Pittman, Amy L., Ramakrishnan, Vijay R., Reed, Jeremy, Sacks, Raymond, Schlosser, Rodney J., Simonsen, Andrew R., Sindwani, Raj, Son, Hwa J., Stamm, Aldo Cassol, Suh, Jeffrey D., Tsao, Gabriel J., Turner, Justin H., Vandergrift, William Alexander, III, Wang, Eric W., Waters, Heather H., Wei, Calvin, Welch, Kevin C., Woodworth, Bradford A., and Wormald, P.J.
- Published
- 2013
- Full Text
- View/download PDF
5. NARCOTIC AGONISTS AND ANTAGONISTS
- Author
-
Lineberger, Catherine K., Ginsberg, Brian, Franiak, Randall J., and Glass, Peter S.A.
- Published
- 1994
- Full Text
- View/download PDF
6. Vaso-occlusive crisis in a sickle cell patient after transfusion-transmitted dengue infection.
- Author
-
Santos FLS, Slavov SN, Bezerra RS, Santos EV, Silva-Pinto AC, Morais ALL, Sá MB, Ubiali EMA, De Santis GC, Covas DT, and Kashima S
- Subjects
- Adult, Female, Humans, Transfusion Reaction blood, Transfusion Reaction physiopathology, Anemia, Sickle Cell blood, Anemia, Sickle Cell physiopathology, Anemia, Sickle Cell therapy, Dengue blood, Dengue etiology, Dengue physiopathology, Dengue Virus, Erythrocyte Transfusion adverse effects, Vasoconstriction
- Abstract
Case Report: A 26-year-old woman with sickle cell disease (SCD) on chronic transfusion therapy complained of severe arthralgia, myalgia, abdominal pain, headache, and fever 24 hours after transfusion of a red blood cells (RBCs). Dengue virus (DENV) infection was suspected and the patient was hospitalized for clinical support and RBC transfusion, to lower the hemoglobin S to less than 30%. The patient's clinical condition improved approximately 8 days after the onset of symptoms., Results: DENV type 2 (DENV-2) TaqMan real-time polymerase chain reaction was negative in the patient's pretransfusion sample while the posttransfusion sample was positive (Ct, 27.8), suggesting a high viral load and an acute infection. To investigate DENV transfusion transmission (TT-DENV) the stored donor serum was tested and was also positive (Ct, 25.8). Molecular typing confirmed the presence of DENV-2. The phylogenetic analysis of the DENV-2 strains obtained from both donor and patient samples were classified as the Southeast Asia-American genotype (Genotype III) and demonstrated 100% genomic identity, indicating TT-DENV., Conclusion: This is the first description of TT-DENV in a SCD patient. A presumed high viral load in the transfused RBC unit probably determined the early clinical manifestation. In endemic regions dengue fever should be considered as differential diagnosis in SCD patients with fever and acute pain crisis, mainly during DENV outbreaks., (© 2020 AABB.)
- Published
- 2020
- Full Text
- View/download PDF
7. Effects of Glyphosate-Based Herbicide Sub-Lethal Concentrations on Fish Feeding Behavior.
- Author
-
Giaquinto PC, de Sá MB, Sugihara VS, Gonçalves BB, Delício HC, and Barki A
- Subjects
- Animals, Dose-Response Relationship, Drug, Eating, Glycine toxicity, Herbicides toxicity, Glyphosate, Feeding Behavior drug effects, Fishes, Glycine analogs & derivatives
- Abstract
Glyphosate-based herbicides are widely used in agricultural systems. Although the target organism are particularly plant organisms, there are numerous studies showing adverse effects in aquatic animals, such as inhibition of acetyl cholinesterase, effects on kidney, liver, and gill and stressors effects. This study analyzed the effects of commercial formulation of glyphosate on feeding behavior in Pacu (Piaractus mesopotamicus). Fish were exposed to three glyphosate concentrations (0.2, 0.6, and 1.8 ppm) for 15 days. At concentrations of 0.2 and 0.6 ppm, food intake decreased on day 13 and then returned to normal on day 15. At the highest glyphosate-based herbicide concentration, 1.8 ppm, food consumption decreased dramatically and did not recover on day 15. This study showed that glyphosate-based herbicide at sub-lethal concentrations can affect feed intake in pacu and consequently inhibits its growth.
- Published
- 2017
- Full Text
- View/download PDF
8. Sleep and circadian alterations in people at risk for bipolar disorder: A systematic review.
- Author
-
Melo MC, Garcia RF, Linhares Neto VB, Sá MB, de Mesquita LM, de Araújo CF, and de Bruin VM
- Subjects
- Humans, Risk Factors, Bipolar Disorder complications, Chronobiology Disorders etiology, Sleep Wake Disorders etiology
- Abstract
Background: Sleep and circadian abnormalities have been mostly demonstrated in bipolar patients. However, it is not clear whether these alterations are present in population at high risk for bipolar disorder (BD), indicating a possible risk factor for this condition., Objective: This systematic review aims to define current evidence about sleep and rhythm alterations in people at risk for BD and to evaluate sleep and circadian disorders as risk factor for BD., Methods: The systematic review included all articles about the topic until February 2016. Two researchers performed an electronic search of PubMed and Cochrane Library. Keywords used were 'sleep' or 'rhythm' or 'circadian' AND 'bipolar disorder' or 'mania' or 'bipolar depression' AND 'high-risk' or 'risk'., Results: Thirty articles were analyzed (7451 participants at risk for BD). Sleep disturbances are frequent in studies using both subjective measures and actigraphy. High-risk individuals reported irregularity of sleep/wake times, poor sleep and circadian rhythm disruption. Poor sleep quality, nighttime awakenings, and inadequate sleep are possible predictive factors for BD. A unique study suggested that irregular rhythms increase risk of conversion. People at risk for BD showed high cortisol levels in different times of day. Studies about anatomopathology, melatonin levels, inflammatory cytokines and oxidative stress were not identified. The most important limitations were differences in sleep and rhythm measures, heterogeneity of study designs, and lack of consistency in the definition of population at risk., Conclusion: Sleep and circadian disturbances are common in people at risk for BD. However, the pathophysiology of these alterations and the impact on BD onset are still unclear., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
9. Phytochemistry and Preliminary Assessment of the Antibacterial Activity of Chloroform Extract of Amburana cearensis (Allemão) A.C. Sm. against Klebsiella pneumoniae Carbapenemase-Producing Strains.
- Author
-
Sá MB, Ralph MT, Nascimento DC, Ramos CS, Barbosa IM, Sá FB, and Lima-Filho JV
- Abstract
The chloroform extract of the stem bark of Amburana cearensis was chemically characterized and tested for antibacterial activity.The extract was analyzed by gas chromatography and mass spectrometry. The main compounds identified were 4-methoxy-3-methylphenol (76.7%), triciclene (3.9%), α -pinene (1.0%), β -pinene (2.2%), and 4-hydroxybenzoic acid (3.1%). Preliminary antibacterial tests were carried out against species of distinct morphophysiological characteristics: Escherichia coli, Salmonella enterica Serotype Typhimurium, Pseudomonas aeruginosa, Staphylococcus aureus, Listeria monocytogenes, and Bacillus cereus. The minimum inhibitory concentration (MIC) was determinate in 96-well microplates for the chloroform extract and an analogue of themain compound identified, which was purchased commercially.We have shown that plant's extract was only inhibitory (but not bactericidal) at the maximum concentration of 6900 μ g/mL against Pseudomonas aeruginosa and Bacillus cereus. Conversely, the analogue 2-methoxy-4-methylphenol produced MICs ranging from215 to 431 μ g/mL against all bacterial species.New antibacterial assays conducted with such chemical compound against Klebsiella pneumoniae carbapenemase-producing strains have shown similarMICresults and minimumbactericidal concentration (MBC) of 431 μ g/mL.We conclude that A. cearensis is a good source of methoxy-methylphenol compounds,which could be screened for antibacterial activity againstmultiresistant bacteria fromdifferent species.
- Published
- 2014
- Full Text
- View/download PDF
10. Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.
- Author
-
Dimopoulos G, Paiva JA, Meersseman W, Pachl J, Grigoras I, Sganga G, Montravers P, Auzinger G, Sá MB, Miller PJ, Marček T, Kantecki M, and Ruhnke M
- Subjects
- Adult, Aged, Aged, 80 and over, Anidulafungin, Critical Illness, Drug-Related Side Effects and Adverse Reactions epidemiology, Female, Humans, Incidence, Male, Middle Aged, Survival Analysis, Treatment Outcome, Antifungal Agents administration & dosage, Antifungal Agents adverse effects, Candidiasis, Invasive drug therapy, Echinocandins administration & dosage, Echinocandins adverse effects
- Abstract
Post hoc analysis of a non-comparative, prospective, multicentre, phase IIIb study was performed to compare efficacy and safety of anidulafungin in elderly (≥65 years) versus non-elderly (<65 years) Intensive Care Unit (ICU) patients with candidaemia/invasive candidiasis (C/IC). Adult ICU patients with confirmed C/IC meeting ≥1 of the following criteria were enrolled: post-abdominal surgery; solid tumour; renal/hepatic insufficiency; solid organ transplantation; neutropenia; age ≥65 years. Patients received anidulafungin (200 mg on Day 1, 100 mg/day thereafter) for ≥10 days followed by optional azole step-down therapy for a total treatment duration of 14-56 days. The primary efficacy endpoint was global (clinical and microbiological) response at the end of all therapy (EOT). Primary efficacy analysis was performed in the modified intent-to-treat (mITT) population (n=170), excluding unknown and missing responses. In total, 80 patients (47.1%) were aged ≥65 years and 90 (52.9%) were aged <65 years; the mean age difference between the two groups was 21.9 years. Global success at EOT in mITT patients was similar in elderly (68.1%) and non-elderly (70.7%) patients (P=0.719). However, global success rates were significantly lower in elderly versus non-elderly patients at 2 and 6 weeks after EOT (P=0.045 and P=0.016, respectively). Ninety-day survival was significantly lower (P=0.006) for elderly (42.8%) versus non-elderly patients (63.3%). The incidence and profile of adverse events were similar in elderly and non-elderly patients. Anidulafungin was effective and safe for treatment of C/IC in elderly ICU patients, despite higher baseline severity of illness scores., (Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
11. Critical overview of clinical guidelines relating to invasive fungal infections.
- Author
-
Sá MB and Zaragoza R
- Subjects
- Humans, Mycoses prevention & control, Guidelines as Topic, Mycoses diagnosis, Mycoses drug therapy
- Abstract
The incidence of invasive fungal infections (IFIs) has continued to grow in recent years. IFIs are associated with significant morbidity and mortality as well as costs. The diagnostic and therapeutic approaches to IFI have changed significantly in recent years, fostered by the introduction of new diagnostic methods and new antifungal products. There are also new therapeutic approaches such as de-escalation, pre-emptive antifungal treatment or combined treatment with antifungals. All of these aspects have been described in many trials, meta-analyses and reviews. There are also different clinical guidelines for IFIs with diagnostic and therapeutic recommendations. They are of unquestionable value and at the same time represent different perspectives on the problem. The lack of homogeneity when selecting and drafting the recommendations is a problem, and some of them are based more on personal opinion than on evidence. In this paper, we have put together a critical overview of the role of guidelines for IFIs, with emphasis on non-neutropenic critical patients.
- Published
- 2008
- Full Text
- View/download PDF
12. Knowledge of newborn health care among pregnant women: basis for promotional and educational programs on breastfeeding.
- Author
-
Issler H, de Sá MB, and Senna DM
- Subjects
- Cross-Sectional Studies, Female, Health Behavior, Health Promotion, Humans, Infant, Newborn, Lactation Disorders physiopathology, Mothers, Pregnancy, Program Development, Breast Feeding, Health Education, Health Knowledge, Attitudes, Practice
- Abstract
Context: Promotional and educational programs relating to breast feeding are important for reversing the decline in this practice. Most programs are centered exclusively on breast feeding, although general knowledge about newborn health care may be important, especially among pregnant women., Objective: To study pregnant women's knowledge about general health care of newborns, including breast feeding aspects., Type of Study: Cross-sectional., Setting: Prof. Samuel Barnsley Pessoa Health School Center, Faculty of Medicine, University of São Paulo, Brazil., Participants: All pregnant women who were registered in the prenatal care program during six consecutive months., Main Measurements: Aspects of the current gestation, previous gestations and childbirth, knowledge of the general aspects of newborn health care and of breast feeding practices., Results: The results show that only a little over half of the pregnant women had received any information on newborn health care. Misinformation was clearly present regarding proper care of the umbilical stump and the nature of jaundice, and worst regarding how to treat oral thrush and jaundice, and about vaccination. In relation to breast feeding, even though almost all the pregnant women declared their intention to breast feeding, less than half had a concrete response regarding how long to do it for. The low rates obtained in the topics dealing with the duration, nursing intervals and the attitude to be taken towards hypogalactia show unfamiliarity with the breast feeding technique. The "weak milk" belief, the misinformation about contraceptive methods during breast feeding and the cost of artificial formulas also have a negative impact on this practice., Conclusions: Pregnant women's knowledge of newborn health care is low, as much in the aspects of general care as in relation to the practice of breast feeding. These findings must be taken into consideration in educative programs promoting breast feeding.
- Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.